home / stock / bntx / bntx articles

BNTX Articles, BioNTech SE

Stock Information
Company Name: BioNTech SE
Stock Symbol: BNTX
Market: NYSE
Website: biontech.de
Menu
BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board
Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B | Benzinga

Wednesday, GSK plc (NYSE:GSK) and CureVac N.V. (NASDAQ:CVAC) announced they have restructured their existing collaboration into a new licensing agr...
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents | Benzinga

Pfizer Inc. (NYSE:PFE) and Moderna Inc. (NASDAQ:MRNA) are set for more legal battles over their rival COVID-19 vaccines after London’s High C...

AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway | Benzinga

On Wednesday, the FDA approved Epkinly (epcoritamab-bysp) as the first and only T-cell-engaging bispecific antibody administered subcutaneousl...

GameStop And First Solar Were Among The 10 Biggest Large Cap Losers Last Week (June 16-June 22): Are These In Your Portfolio? | Benzinga

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio? GameStop Corp (NYSE:GME) shares lost 18.61% in ...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment | Benzinga

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its ...

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? | Benzinga

BioNTech SE’s (NASDAQ:BNTX) partner MediLink Therapeutics (Suzhou) Co., Ltd says the FDA has placed a partial clinical hold on the Phase 1 tr...

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season | Benzinga

On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which target...
What's Going On With Novavax Stock? | Benzinga

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at w...

Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer called Celestica Inc. (NYSE:CLS) “terrific” after the Toronto-based ...

Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio? | Benzinga

These large-cap stocks were the best performers in the last week. Are they in your portfolio? First Solar, Inc. (NASDAQ:FSLR) shares jumped 41.5%...
Next 10